{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:37:43Z","timestamp":1789864663753,"version":"4.0.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T00:00:00Z","timestamp":1215561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p><jats:bold>Background and Objective\u2002<\/jats:bold> To investigate the physico\u2010chemical properties of hepatitis E virus (HEV) with regard to inactivation\/removal, we have studied four isolates with respect to sensitivity to heat during liquid\/dry\u2010heating as well as removal by nanofiltration.<\/jats:p><jats:p><jats:bold>Materials and Methods\u2002<\/jats:bold> Hepatitis E virus in an albumin solution or phosphate\u2010buffered saline (PBS) was liquid\u2010heated at 60\u00b0C for a preset time. HEV in a freeze\u2010dried fibrinogen containing stabilizers was also dry\u2010heated at 60 or 80\u00b0C for a preset time. In addition, to clarify the removal of HEV, the purified virus in PBS was filtered using several types of virus\u2010removal filter (nanofilters) that have different pore sizes. HEV infectivity or genome equivalents before and after the treatments were assayed by a semiquantitative cell\u2010based infectivity assay or quantitative polymerase chain reaction assay, respectively.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Hepatitis E virus isolates in albumin solutions were inactivated slowly at 60\u00b0C for 5\u00a0h and the resultant log reduction factor (LRF) was from 1\u00b70 to \u2265\u00a02\u00b72, whereas the virus in PBS was inactivated quickly to below the detection limit and the LRF was \u2265\u00a02\u00b74 to \u2265\u00a03\u00b77. The virus in a freeze dried fibrinogen containing trisodium citrate dihydrate and <jats:sc>l<\/jats:sc>\u2010arginine hydrochloride as stabilizers was inactivated slowly and the LRF was 2\u00b70 and 3\u00b70, respectively, of the 72\u00a0h at 60\u00b0C, but inactivated to below the detection limit within 24 h at 80\u00b0C with an LRF of \u2265\u00a04\u00b70. The virus in PBS was also confirmed as to be approximately 35\u00a0nm in diameter by nanofiltration. These results are useful for evaluating viral safety against HEV contamination in blood products.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> The sensitivity of HEV to heat was shown to vary greatly depending on the heating conditions. On the other hand, the HEV particles were completely removed using 20\u2010nm nanofilters. However, each inactivation\/removal step should be carefully evaluated with respect to the HEV inactivation\/removal capacity, which may be influenced by processing conditions such as the stabilizers used for blood products.<\/jats:p>","DOI":"10.1111\/j.1423-0410.2008.01078.x","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T11:57:45Z","timestamp":1215604665000},"page":"94-100","source":"Crossref","is-referenced-by-count":35,"title":["Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters"],"prefix":"10.1111","volume":"95","author":[{"given":"M.","family":"Yunoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Adan\u2010Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Urayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,9]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"853","volume-title":"Virus Taxonomy: Eighth Report of the International Committee on the Taxonomy of Viruses","author":"Emerson SU","year":"2005"},{"key":"e_1_2_6_3_2","first-page":"90","article-title":"International collaborative survey on epidemiology of hepatitis E virus in 11 countries","volume":"37","author":"Abe K","year":"2006","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80319-0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19242-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1112.051041"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.10.006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03300.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00939-06"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82613-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20364"},{"key":"e_1_2_6_12_2","unstructured":"Ministry of Health Labour and Welfare Japan: Conference documents of the subcommittee of safety control technologies on blood products of 1st conference in 2005 [In Japanese]. Available athttp:\/\/www.mhlw.go.jp\/shingi\/2005\/10\/s1020\u20101.html"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20125"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.6.5.729-733.1999"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/432488"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82535-0"},{"key":"e_1_2_6_17_2","unstructured":"National Institute of Infectious Diseases Japan:Test for Moisture Content in Minimum Requirements for Biological Products2006:280.Available athttp:\/\/www.nih.go.jp\/niid\/MRBP\/index\u2010e.html"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874318807001010001"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00845.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00879.x"},{"key":"e_1_2_6_21_2","unstructured":"YunokiM:Usefulness of Planova filtration in virus inactivation\/removal. Planova workshop 2000 (Tokyo Japan)"},{"key":"e_1_2_6_22_2","unstructured":"YunokiM:Evaluation of the ability of Planova filtration to eliminate infectious pathogens. Planova workshop 2003 (Tokyo Japan)"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00864.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00515.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18918-0"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.482"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2005.07.004"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2008.01078.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2008.01078.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T22:44:06Z","timestamp":1696891446000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2008.01078.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1423-0410.2008.01078.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2008.01078.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,9]]}}}